Moreover, in several human malignancies including MPM, CRC and chronic myeloid leukemia, CD26/DPPIV expression is reported to be a marker of cancer stem cells [15–18]. Here, DPP4 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.